Radiation therapy raises $11 million: Sensus Healthcare prices upsized IPO below the range at $5.50
Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, raised $11 million by offering 2 million units at $5.50.
Sensus originally planned to raise $20 million in March at a market cap of $97 million, but postponed the deal. It came back in May with a new underwriter and stapled warrants at a proposed price of $6.25 ($80 million market cap). Sensus Healthcare plans to list on the Nasdaq under the symbol SRTSU. Northland Securities and Neidiger, Tucker, Bruner acted as lead managers on the deal.
The article Radiation therapy raises $11 million: Sensus Healthcare prices upsized IPO below the range at $5.50 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.